GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Redcare Pharmacy NV (HAM:RDC) » Definitions » Research & Development

Redcare Pharmacy NV (HAM:RDC) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Redcare Pharmacy NV Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Redcare Pharmacy NV's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Redcare Pharmacy NV Research & Development Historical Data

The historical data trend for Redcare Pharmacy NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redcare Pharmacy NV Research & Development Chart

Redcare Pharmacy NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Redcare Pharmacy NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Redcare Pharmacy NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV  (HAM:RDC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Redcare Pharmacy NV Research & Development Related Terms

Thank you for viewing the detailed overview of Redcare Pharmacy NV's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Redcare Pharmacy NV (HAM:RDC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Redcare Pharmacy NV (HAM:RDC) » Definitions » Research & Development
Comparable Companies
HQL FMY MIN GGT PHD CBH HTY PZC ERC PCK WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391
Traded in Other Exchanges
SAEYY:USA RDCd:UK 0RJT:UK RDC:Germany SHOP:Austria
Address
Erik de Rodeweg 11/13, Sevenum, NLD, 5975 WD
Website
https://www.shop-apotheke.com
Redcare Pharmacy NV Formerly Shop Apotheke Europe NV operates an online pharmacy store. Its product portfolio is focused on non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Belgium, Spain, France, and Italy.